Biotech · Private company
MeiraGTx Ocular UK Ltd
Track this companyFree. Adds MeiraGTx Ocular UK Ltd to your Dealase workspace and tells you when its record changes.
Clinical trials42 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- Genetic: AAV5-hRKp.RPGRPhase 3 · X-Linked Retinitis PigmentosaClinicalTrials.gov · fetched Nov 12, 2026
- Genetic: AAV5-hRKp.RPGR Intermediate DosePhase 3 · X-Linked Retinitis PigmentosaClinicalTrials.gov · fetched Nov 12, 2026
- Genetic: AAV5-hRKp.RPGR Low DosePhase 3 · X-Linked Retinitis PigmentosaClinicalTrials.gov · fetched Nov 12, 2026
- AAV5-hRKp.RPGRPhase 2 · X-Linked Retinitis PigmentosaClinicalTrials.gov · fetched Nov 12, 2026
- No intervention (Follow-Up assessment)Phase 2 · X-Linked Retinitis PigmentosaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- A Follow-on Study for Second-Eye Treatment for Participants Previously Treated With Gene Therapy for X-Linked Retinitis Pigmentosa (XLRP)PHASE2 · ACTIVE_NOT_RECRUITING · started Oct 10, 2024ClinicalTrials.gov NCT06646289 · fetched Nov 12, 2026
- Follow-up Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR GenePHASE3 · ACTIVE_NOT_RECRUITING · started Dec 4, 2020ClinicalTrials.gov NCT04794101 · fetched Nov 12, 2026
- Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR GenePHASE3 · COMPLETED · started Dec 4, 2020ClinicalTrials.gov NCT04671433 · fetched Nov 12, 2026
- Long-term Follow-up Gene Therapy Study for RPGR- XLRPCOMPLETED · started Jul 31, 2017ClinicalTrials.gov NCT04312672 · fetched Nov 12, 2026